Andrew, I've explained my post on the Argo forum and how is it very different from what you accuse me of.
I see by your messages that you seem fustrated and I think that fustration is clouding your judgement.
I haven't lied in any of my messages on this board. Out of respect for the other members on this board I'll leave this conversation here as it is an unnecessary distraction that you have brought up out of thin air.
I didn't downtalk or lie about Synairgen in any way with my post. My response to the person on the Argo forum was because of a lie they had repeated. Would you perhaps that I had lied and said Synairgen were included in the 5 EU therapeutics?
I think you are letting your emotions run a little wild here. And I think the hypocrite comment is uncalled for as I have not done anything to earn that. I was an early investor here and still wish the company the best despite my reduction.
Andrewpcapp, I was replying to s120896 regarding the EU therapeutics and referencing the original poster. I think I'm allowed to do that. I fail to see the need for you to post this and comment on my investments which you know nothing about. I also don't understand the need for you to resort to personal messages of this perticular tone. I think a little civility would go a long way on these boards. To ease you mind my investments are doing very well and I hope the same for you.
I see the loan as a smart growth move from PW. I think we'll see a follow up RNS very shortly which I think will involve new machines which is something that is not priced in and would increase revenue and HODL. It would effectively pay for itself as the other machines have (see financial RNS) which is why it is such a good move in my opinion. And don't forget the Texas Facility begins construction the first week of July with completion date on time. Have a good day all
s120896, see xviolet's post, the 5 were chosen by the EU yesterday.
"Jun 29 (Reuters) – The European Commission on Tuesday chose four antibody treatments and a rheumatoid arthritis drug re-targeted by Eli Lilly for an initial portfolio of preferred drugs to treat COVID-19 disease.
The drug selection is part of the EU Strategy on COVID-19 Therapeutics, launched in May, to accelerate EU approval and for a joint procurement plan on behalf of Member States, complementing more advanced efforts in vaccines matter.
The Commission’s selection of most promising treatments includes Eli Lilly and Incyte’s Olumiant for hospitalized COVID-19 patients receiving oxygen, as well as new antibody drugs for early-stage disease developed by Regeneron, Eli Lilly, Celltrion and an alliance of GlaxoSmithKline and its partner Vir."
Hexham, it is the follow up RNS which is what I am looking forward to as I strongly believe it will be machine related. Today's RNS was brilliant as it gave Argo access to funds instantly. It's smart and quick growth for the company which in my opinion again shows that PW has a knack of getting ahead of the competition.
RE: Does Winnifrith have a point?29 Jun 2021 10:38
Probably should point out that 'Buster_Pila' has been spreading lies quite aggressively about Argo for a while now on twitter (same handle on twitter). And as for Tom Winnifrith.. well I think most know what kind of person he is.